z-logo
open-access-imgOpen Access
Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis
Author(s) -
Tomoo Kishaba
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.10.84
Subject(s) - medicine , idiopathic pulmonary fibrosis , dlco , exacerbation , pulmonary function testing , vital capacity , pulmonary fibrosis , lung , diffusing capacity , progressive disease , interstitial lung disease , refractory (planetary science) , cardiology , gastroenterology , disease , lung function , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom